The current status of somatostatin receptors in malignant melanoma.

por Fletcher, W. S., Lum, S. S., Nance, R. W., Pommier, R. F., O'Dorisio, M. S.
Publicado 1997

Feasibility and advantage of adding (131)I-MIBG to (90)Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors

por Bushnell, David L, Madsen, Mark T, O’cdorisio, Thomas, Menda, Yusuf, Muzahir, Saima, Ryan, Randi, O’dorisio, M Sue
Publicado 2014

VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

por Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuki, O’Dorisio, M Sue, Waschek, James A., Tan, Yossan-Var
Publicado 2016

Erratum to: VPAC1 receptor (Vipr1)-deficient mice exhibit ameliorated experimental autoimmune encephalomyelitis, with specific deficits in the effector stage

por Abad, Catalina, Jayaram, Bhavaani, Becquet, Laurine, Wang, Yuqi, O’Dorisio, M. Sue, Waschek, James A., Tan, Yossan-Var
Publicado 2017

Growing vascular endothelial cells express somatostatin subtype 2 receptors

por Watson, J C, Balster, D A, Gebhardt, B M, O'Dorisio, T M, O'Dorisio, M S, Espenan, G D, Drouant, G J, Woltering, E A
Publicado 2001

Addition of (131)I-MIBG to PRRT ((90)Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors

por Bushnell, David L., Bodeker, Kellie L., O’Dorisio, Thomas M., Madsen, Mark T., Menda, Yusuf, Graves, Stephen, Zamba, Gideon K.D., O’Dorisio, M. Sue
Publicado 2021

Safety and Efficacy of Peptide-Receptor Radionuclide Therapy in Elderly Neuroendocrine Tumor Patients

por Theiler, Deborah, Cattaneo, Marco, Dierickx, Lawrence O., Igaz, Peter, Grozinsky-Glasberg, Simona, Bournaud, Claire, O’Dorisio, Thomas, O’Dorisio, M. Sue, Wild, Damian, Christ, Emanuel, Nicolas, Guillaume P.
Publicado 2021

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

por Zaknun, John J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J.
Publicado 2013

Erratum to: The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

por Bodei, L., Mueller-Brand, J., Baum, R. P., Pavel, M. E., Hörsch, D., O’Dorisio, M. S., O’Dorisio, T. M., Howe, J. R., Cremonesi, M., Kwekkeboom, D. J., Zaknun, J. J.
Publicado 2013

Auranofin Inhibition of Thioredoxin Reductase in a Preclinical Model of Small Cell Lung Cancer

por Johnson, Spenser S., Liu, Dijie, Ewald, Jordan T., Robles-Planells, Claudia, Bayanbold, Khaliunaa, Wels, Brian R., Solst, Shane R., O’Dorisio, M. Sue, Allen, Bryan G., Menda, Yusuf, Spitz, Douglas R., Fath, Melissa A.
Publicado 2023

G-protein coupled receptor expression patterns delineate medulloblastoma subgroups

por Whittier, Kelsey L, Boese, Erin A, Gibson-Corley, Katherine N, Kirby, Patricia A, Darbro, Benjamin W, Qian, Qining, Ingram, Wendy J, Robertson, Thomas, Remke, Marc, Taylor, Michael D, O’Dorisio, M Sue
Publicado 2013

Prospective Analysis of the Impact of (68)Ga-DOTATOC Positron Emission Tomography–Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine Tumors

por Ghobrial, Silvia N., Menda, Yusuf, Zamba, Gideon K., Mott, Sarah L., Gaimari-Varner, Kristin, Dick, David, Dillon, Joseph, Howe, James R., Graham, Michael, Sunderland, John, Bellizzi, Andrew, O’Dorisio, Thomas M., O’Dorisio, M. Sue
Publicado 2020

Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma

por Jha, Abhishek, de Luna, Kristine, Balili, Charlene Ann, Millo, Corina, Paraiso, Cecilia Angela, Ling, Alexander, Gonzales, Melissa K., Viana, Bruna, Alrezk, Rami, Adams, Karen T., Tena, Isabel, Chen, Alice, Neuzil, Jiri, Raygada, Margarita, Kebebew, Electron, Taieb, David, O'Dorisio, M. Sue, O'Dorisio, Thomas, Civelek, Ali Cahid, Stratakis, Constantine A., Mercado-Asis, Leilani, Pacak, Karel
Publicado 2019

Establishment of Novel Neuroendocrine Carcinoma Patient-Derived Xenograft Models for Receptor Peptide-Targeted Therapy

por Tran, Catherine G., Borbon, Luis C., Mudd, Jacqueline L., Abusada, Ellen, AghaAmiri, Solmaz, Ghosh, Sukhen C., Vargas, Servando Hernandez, Li, Guiying, Beyer, Gabriella V., McDonough, Mary, Li, Rachel, Chan, Carlos H.F., Walsh, Susan A., Wadas, Thaddeus J., O’Dorisio, Thomas, O’Dorisio, M Sue, Govindan, Ramaswamy, Cliften, Paul F., Azhdarinia, Ali, Bellizzi, Andrew M., Fields, Ryan C., Howe, James R., Ear, Po Hien
Publicado 2022